Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Vall d’Hebron is part of the new Barcelona Medical Photonics network

8 prominent health institutions in the Barcelona area, including Vall d'Hebron, and ICFO join forces through the creation of a network to bring cutting-edge photonic technologies to hospitals.

News

A study where Vall d’Hebron participates analyses the risk genetic factors shared between ADHD and disruptive behaviour disorders

In the work, published in Nature Communications, have participated Dr. Marta Ribasés and Dr. Josep Antoni Ramos Quiroga, from the Psychiatry, Mental Health and Addictions group at the VHIR.

News

Vall d’Hebron maintains its commitment to pediatric cancer research

Today, February 15, it's the International Day of Childhood Cancer.

News

Vall d’Hebron develops a calculator to determine the risk of complications in fetuses with growth restriction

This methodology will make it possible to offer, from the moment of diagnosis, individualized counseling to pregnant women about possible problems during pregnancy, as well as the probability of having a premature birth.

News

CARBALIVE announces positive results of their trial for a novel treatment for cirrhosis

This European consortium, led by the University College of London and funded by the European Union's Horizon 2020 research and innovation program, involves researchers from the Liver Diseases group at the VHIR.

News

Today, we celebrate the International Day of Women and Girls in Science

From Vall d'Hebron, we are aimed at ensuring gender issues in VHIR research and promoting female leadership.

News

A Vall d'Hebron study shows that more than half of pregnant women suffered from symptoms of depression or anxiety during lockdown

During lockdown, 38% of pregnant women had symptoms of depression and 59% had symptoms of anxiety, a much higher percentage than has been demonstrated in the general population.

News

Experts highlight the importance of care management and research in oncology during the World Cancer Day

Coinciding with World Cancer Day, the Vall d'Hebron Campus has organized a conference to analyze the present and future of this disease.

News

The VHIR participates in a study that helps define how sequencing data will be used for the diagnosis of cancers associated with variants of the ATM gene

The VHIR has participated in a study, published by the journal Clinical Chemistry, which has helped to define how the sequencing data will be used for the diagnosis of cancers associated with variants of the ATM gene.

News

MiMARK, a new spin-off of Vall d’Hebron, obtains €1.5M from the Wild Card 2020 program of EIT Health to advance the diagnosis of endometrial cancer

The diagnostic kit has been developed under the leadership of Dr. Eva Colás and Dr. Antonio Gil from the Biomedical Research in Gynecology group at the Vall d'Hebron Research Institute and the Gynecology Service at Vall d'Hebron Hospital.

News

Vall d’Hebron studies the benefits of horse-assisted rehabilitation in recovery of children after cancer treatment

The hippotherapy sessions consist of activities that improve physical variables such as balance or coordination, and other psychic variables such as general health, anxiety, depression, state of mind or sociability.

News

Created BSURE Medical, a new spin-off of the VHIR

The creation of BSURE Medical represents the culmination of the valuation and transfer strategy carried out by the VHIR Innovation Unit of a research project of which Dr. Jaume Alijotas Reig and Dr. Simo Schwartz Jr are the main researchers and promoters.

News

Vall d'Hebron will study the placental tissue of women infected by the SARS-CoV-2 virus during pregnancy

The study is carried out together with the Italfarmaco group and is analyzing the placentas of approximately 100 women who have suffered COVID-19 during their pregnancy.

News

Bufa la bombolla reaches its goal and raises 10.000 euros for research in primary immunodeficiencies

The benefits of the solidarity campaign of Vall d'Hebron and the Barcelona PID Foundation are dedicated to research in primary immunodeficiencies at the Vall d'Hebron Research Institute (VHIR). The initiative had the support of Abacus, which has been the point of sale for the solidarity jars of Bufa

News

Five professionals from Vall d’Hebron, among the top 100 in the State according to Forbes magazine

Forbes magazine has published the list "The best doctors", which recognizes the 100 most relevant medical professionals, divided into 24 specialties.

News

VHIR opens the Seniority Call in the modalities of ERC and No ERC

The Vall d'Hebron University Hospital Foundation - Research Institute (VHIR) makes its own, open and unique call, for the recruitment of excellent researchers.

News

Inauguration of the exhibition of scientific photographs of Vall d’Hebron at Palau Robert

The exhibition 'L'altra mirada de la recerca' (The Other Look at Research) can be visited at Palau Robert from 13th January to 28th February.

News

Patented a peptide that allows faster internalization of drugs within cells and the design of more effective therapeutic nanoconjugates

The CIBBIM-Nanomedicine: Drug Delivery and Targeting research group at the Vall d'Hebron Institute of Research (VHIR), led by Dr. Simó Schwartz Jr, has developed this promising technology, now patented.

News

A study in which the VHIR has participated discovers a new pediatric disease

The VHIR has recently participated in an international study, coordinated by the Children's Hospital of Philadelphia, which has led to the discovery of a new pediatric neurodegenerative disease.

News

New position paper on the design of clinical trials in patients with decompensated cirrhosis

This guide has been carried out within the LiverHope Consortium, founded by the European Commission under the Horizon 2020 program.